Several energizing discussions during my visit to DC this week around healthcare policy reforms to promote building and healthy competition: ➡️Payment paradigms for AI-based care models - how can we leapfrog the ills of our current reimbursement system and develop new ways to pay for services in a world of more AI-enabled labor abundance and consumer-directed spend (more to come on this!) ➡️HTI-5 - unleashing more market-driven competition in HCIT; for all of the vilification of payors and PBMs, those markets are way more competitive than certain HCIT markets! ➡️Interoperability in an AI context - as AI becomes a new site of care, the center of gravity of healthcare data is rapidly moving beyond just traditional medical records, and consumer-directed health engagement through AI apps is breaking the context under which legacy data sharing rules were defined ➡️Affordability of big ticket therapies - novel CGT financing strategies, much of which could ultimately be generalized to other high-cost interventions with long ROI time horizons ➡️Healthtech infrastructure - ways the government can incentive the development of modern tech utilities that enable more real-time administrative transactions I’ve always viewed healthcare as an industry where (de)regulation can be a catalyst for category creation, and this era is no different. Great to see how motivated DC leaders are to stay apprised of the great work of healthtech builders across the country, and to use those insights to inform how our policy frameworks need to evolve to contemplate all the ways by which technology can benefit our healthcare system.